Shares of AbCellera Biologics Inc. (NASDAQ:ABCL - Get Rating) saw strong trading volume on Thursday following insider buying activity. 64,282 shares were traded during mid-day trading, a decline of 97% from the previous session's volume of 2,225,388 shares.The stock last traded at $8.51 and had previously closed at $7.96.Specifically, major shareholder Holdings Ltd. Thermopylae acquired 64,545 shares of the firm's stock in a transaction dated Monday, June 6th. The stock was acquired at an average price of $7.50 per share, for a total transaction of $484,087.50. Following the purchase, the insider now owns 55,580,303 shares of the company's stock, valued at approximately $416,852,272.50. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Also, CFO Andrew Booth acquired 85,000 shares of the firm's stock in a transaction dated Thursday, May 12th. The stock was bought at an average price of $5.79 per share, with a total value of $492,150.00. Following the purchase, the chief financial officer now directly owns 138,500 shares in the company, valued at approximately $801,915. The disclosure for this purchase can be found here. Over the last ninety days, insiders acquired 1,758,013 shares of company stock valued at $11,272,517. 45.80% of the stock is currently owned by corporate insiders.
https://www.marketbeat.com/instant-alerts/nasdaq-abcl-volume-advance-2022-06/
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.